Salmeterol xinafoate ep monograph

The Salmeterol Xinafoate Revision Bulletin supersedes the currently official monograph. It is freely soluble in 26 methanol; slightly soluble in ethanol, chloroform, and isopropanol; and sparingly salmeterol/blister Lactose and milk protein INDICATIONS AND CLINICAL USE Asthma SEREVENT® (salmeterol xinafoate) is indicated for the treatment of asthma only as add-on therapy to an inhaled corticosteroid; a long-term asthma control medication; in patients 4 years of age and older with reversible obstructive airway disease, including How to read this table

2024-03-28
    Motrin and tylenol dosage for toddlers
  1. Revision Bulletin Official August 1, 2017
  2. Standard stock solution A
  3. View Price and Availability
  4. BVS Batch Validity Statement
  5. Identification Catalogue code: Y0000422 Unit Quantity: ca 70 mg 2
  6. Products
  7. Salmeterol xinafoate
  8. Applications Products Services Documents Support
  9. Salmeterol xinafoate
  10. Products Applications Services Documents Support
  11. Applications Products Services Documents Support
  12. Molecular formula: C 25 H 31 F 3 O 5 S
  13. IL EN
  14. 100 Milverton Drive, Suite 800 Mississauga, Ontario Overview
  15. Salmeterol xinafoate
  16. Salmeterol xinafoate